Bupropion (Wellbutrin, Zyban) is a unique but commonly prescribed antidepressant that inhibits the reuptake of dopamine and norepinephrine. It is FDA approved for the treatment of major depressive disorder, seasonal affective disorder, and smoking cessation. It is commonly used off-label for the treatment of attention deficit hyperactivity disorder (ADHD).
Anecdotally there have long been reports of abuse and diversion of bupropion in jails and prisons. In my own personal experience in these settings, I have not seen much evidence of such misuse. Inmates rarely present to me seeking this medication. By contrast, and about which I have previously written, quetiapine (Seroquel) is highly desired medication in corrections.
I conducted a literature search on this topic and
Continue reading »
Attention deficit hyperactivity disorder (ADHD), characterized by such symptoms as hyperactivity, impulsivity, and inattention, was previously thought of as a childhood condition that children eventually would outgrow. In recent years, we have realized that ADHD symptoms do not necessarily disappear or lessen by adulthood for many.
In the highly structured prison setting, untreated ADHD does not typically impair daily functioning to the degree that it might for those in the community. Nonetheless, some inmates with untreated ADHD may get into altercations with others and receive conduct reports for violating prison rules because of their impulsivity. Likewise, others may not do as well in prison educational and rehabilitation programs because of difficulty concentrating and staying organized.
Continue reading »
Recent Comments